- As China Slows Down, the Philippines Moves to Grab Foreign Investment
- Why Obamacare Subsidies Should Be Struck Down by the Supreme Court
- MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
- Shale Oil Bust Enters Phase Two, Led by Hercules and SandRidge
- Comcast Wants Congress to Gut the New Net Neutrality Rules
Israel's stock market has boomed the past two years, but the recent events in Egypt are giving some investors pause.
Barry Sheked believes keen competition can only help the software company.
Stocks are fueled by a host of bullish corporate and economic news.
Israel's largest cellular-phone carrier hopes to raise more than $300 million in an IPO.
Teva, Check Point and M-Systems are among the familiar names in the new country index.
A growing stake by BlackRock could suggest a shakeup at the top.
Shares of the Israeli generic-drug maker could take a hit.
Tzvika Friedman discusses his company's growth strategy in an increasingly competitive market.
Freescale's buyout gets hopes up for a 'wall of money' into the Israeli high-tech industry.